Eagle Pharmaceuticals Inc (EGRX.OQ)
EGRX.OQ on NASDAQ Stock Exchange Global Market
50.66USD
16 Nov 2018
50.66USD
16 Nov 2018
Change (% chg)
$0.22 (+0.44%)
$0.22 (+0.44%)
Prev Close
$50.44
$50.44
Open
$50.24
$50.24
Day's High
$51.43
$51.43
Day's Low
$49.75
$49.75
Volume
102,989
102,989
Avg. Vol
93,317
93,317
52-wk High
$85.66
$85.66
52-wk Low
$46.88
$46.88
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 1.15 | December | 17 Nov 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 3 | 3 | 3 |
| (3) HOLD | 3 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.40 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 5 | 54.17 | 58.30 | 49.90 | 55.10 |
| Quarter Ending Mar-19 | 3 | 55.60 | 58.70 | 52.90 | -- |
| Year Ending Dec-18 | 5 | 211.43 | 215.50 | 207.20 | 214.60 |
| Year Ending Dec-19 | 5 | 231.63 | 250.54 | 218.60 | 247.57 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 4 | 1.15 | 1.34 | 0.85 | 1.18 |
| Quarter Ending Mar-19 | 2 | 1.05 | 1.16 | 0.94 | -- |
| Year Ending Dec-18 | 4 | 3.70 | 3.99 | 3.31 | 4.37 |
| Year Ending Dec-19 | 4 | 4.52 | 5.45 | 3.74 | 5.04 |
| LT Growth Rate (%) | 1 | 0.30 | 0.30 | 0.30 | 15.00 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-18 | 53.43 | 51.34 | 2.10 | 3.92 |
| Quarter Ending Jun-18 | 51.23 | 59.30 | 8.07 | 15.74 |
| Quarter Ending Mar-18 | 48.88 | 46.63 | 2.25 | 4.60 |
| Quarter Ending Dec-17 | 52.91 | 46.78 | 6.12 | 11.58 |
| Quarter Ending Sep-17 | 51.86 | 63.02 | 11.16 | 21.53 |
| Earnings (per share) | ||||
| Quarter Ending Sep-18 | 0.98 | 1.18 | 0.20 | 20.41 |
| Quarter Ending Jun-18 | 0.80 | 0.95 | 0.15 | 18.45 |
| Quarter Ending Mar-18 | 0.69 | 0.53 | 0.16 | 22.63 |
| Quarter Ending Dec-17 | 1.00 | 1.00 | 0.00 | 0.50 |
| Quarter Ending Sep-17 | 0.80 | 1.22 | 0.42 | 52.98 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 54.17 | 54.17 | 60.51 | 60.94 | 55.10 |
| Quarter Ending Mar-19 | 55.60 | 55.60 | 56.60 | 57.20 | -- |
| Year Ending Dec-18 | 211.43 | 211.43 | 221.57 | 222.28 | 214.60 |
| Year Ending Dec-19 | 231.63 | 231.63 | 245.57 | 257.98 | 247.57 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 1.15 | 1.15 | 1.38 | 1.33 | 1.18 |
| Quarter Ending Mar-19 | 1.05 | 1.05 | 1.18 | 1.18 | -- |
| Year Ending Dec-18 | 3.70 | 3.70 | 3.83 | 3.49 | 4.37 |
| Year Ending Dec-19 | 4.52 | 4.52 | 4.37 | 4.56 | 5.04 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 5 |
| Quarter Ending Mar-19 | 0 | 0 | 1 | 1 |
| Year Ending Dec-18 | 0 | 0 | 0 | 5 |
| Year Ending Dec-19 | 0 | 0 | 1 | 4 |
| Earnings | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 3 |
| Quarter Ending Mar-19 | 0 | 0 | 0 | 1 |
| Year Ending Dec-18 | 0 | 0 | 1 | 2 |
| Year Ending Dec-19 | 0 | 0 | 2 | 2 |
Earnings vs. 
Estimates